Scientists at EMBL's European Bioinformatics Institute (EMBL-EBI) and the Wellcome Sanger Institute have discovered significant diversity in the genomes of 16 laboratory strains of mouse, potentially impacting future research in genetics, drug development and beyond.
Newly sequenced mouse genomes unearth unknown genes
The research, published in the journal Nature Genetics, produced draft genome sequences for 16 of the most widely used mouse strains, revealing, for the first time, notable genetic diversity. Significant areas of the genome where variation was found include regions impacting immunity, pathogen defence and sensory function. These variations also differ widely from the current reference strain, suggesting this discovery has the potential to significantly impact future human disease research.
A research staple
The lab mouse is a staple of research in understanding health and disease, drug development, vaccines and genetics, and is the most widely used mammalian model organism. Its similarity to the human genome, with 98 per cent of genes comparable to those in humans, has made the mouse genome instrumental in helping researchers understand disease and develop drug treatments.
Researchers use a variety of different mouse strains to study human disease. For example the Non-obese Diabetic (NOD) mouse is used to study type 1 diabetes. Prior to the current study, researchers only had the complete genome for one of these strains. By sequencing 16 of the most commonly used mouse strains, this study discovered hundreds of new forms of genes associated with disease, as well as a previously unknown gene. This is one of the largest known mouse genes to date, and has been associated with brain development.
“We examined the regions of the genome that were most different compared to the single genome that the whole community is using. One of the most striking things we found is that genes important for disease research were the most highly-variable genes. We looked in detail at a few of these regions and found completely different gene structures compared to the reference strain.
“If you’re using mice for your experiments you need to be aware of the diversity that’s present in those types of genes. What we’ve generated is a resource for the community.”
Thomas Keane, Faculty member at EMBL-EBI
“Mice have played a critical role in defining the genetics of mammalian development and for modelling human disease. We have known for some time that there are differences between mouse strains in phenotypes such as response to viruses and pathogens. These genomes allow us to understand these differences, which could have profound implications for human disease research.”
David Adams, Senior Group Leader at the Wellcome Sanger Institute
Compared to previous research in this area this study constructed whole genome sequences rather than just looking at differences between strains. The ability to see across whole loci or regions means researchers will be able to study these variations and differences in a wider context, rather than just looking at individual differences.
These findings have the potential to impact the future of genetics research, drug development and the way in which research is carried out. The resource has now been made available to the wider scientific community. The 16 genomes have been incorporated into Ensembl, where they can be freely accessed and analysed.
Image: Newly sequenced mouse genomes have revealed new gene structures and coding loci absent from the current reference strain. This discovery could impact future research in genetics, drug development and beyond.
The Wellcome Sanger Institute is one of the premier centres of genomic discovery and understanding in the world. It leads ambitious collaborations across the globe to provide the foundations for further research and transformative healthcare innovations.